Agrow Allied Ventures Ltd going strong with a revenue growth at 38% and PAT growing 160% from last financial year

Agrow Allied Ventures ltd (AAVPL) is maintaining a steady growth rate by topline increasing with 38% and PAT increasing by 160% since last financial year. Both domestic and exports market has equally contributed to the revenue growth. 

The main reason for maintaining healthy growth rate was company’s strong technical portfolio and export growth with global presence in more than 70 countries backed up by registrations . 

Today AAVPL is manufacturing more than 12 active technical which includes 2,4-D Series ( Acid , amines , salts , ester )/ Metribuzin / Pretilachlor / Bisypribac Sodium / Clodinafop /  Thiamethoxam / Bifenthrin / Lamda Cyhalothrin / Tricyclazole / Thiophanate Methyl etc.  

In export market , AAVPL is continuously receiving registrations in regulated and semi regulated markets which is boosting exports sales. 

AAVPL is optimistic to maintain strong growth in future as well as its continuously expanding its technical capacity. Company is expecting registrations for new high value technical products in this financial year for which they are prepared to start production. AAVPL also in setting up a state of art new formulation plant which is expected to be completed by November this year. The formulation plant is planned to enhance production capacity for growing export and domestic market demand . With the good monsoon expected in India and global demand to bounce back post COVID situation with opening up of world economies , company is confident to show strong results in this financial year as well.